Meyers R L
Int Ophthalmol Clin. 1975 Winter;15(4):37-47. doi: 10.1097/00004397-197501540-00005.
The accompanying inflammation seen in ocular HSV infection-the result of interactions between viruses and the immune response-can be both beneficial and potentially harmful to the host. An understanding of the interaction of virus-immune cells is just evolving from current advances in basic research. Based on our studies on HSV keratitis [11], the control of ocular HSV infection appears to involve an early inflammatory phase with macrophage reactivity and elaboration of MIF. Transient virus-specific lymphocytes with effector reactivity, as well as neutrophils with chemotactic activity, occur during the stromal keratitis. Finally, antibody-dependent complement-mediated lysis provides another phase of restriction of infection. Thus, a rationale for effective management and therapy of occular HSV disease must be based on an understanding of (1) the immunological and immunopathological mechanisms of corneal inflammatory disease initiated by the virus; (2) the immunological mechanisms in recovery from the disease; and (3) the host's humoral and cellular immune status during virus persistence (latency) and during recurrent episodes of infection. We hope that new information obtained from assessment of roles of the humoral and cellular immune responses in recovery from disease and in recurrent disease will provide new approaches to the management of ocular HSV infections.
眼部单纯疱疹病毒(HSV)感染中伴随出现的炎症——病毒与免疫反应相互作用的结果——对宿主而言可能既有益又有潜在危害。目前基础研究的进展刚刚开始揭示病毒与免疫细胞之间相互作用的奥秘。基于我们对HSV角膜炎的研究[11],眼部HSV感染的控制似乎涉及一个早期炎症阶段,此阶段巨噬细胞发生反应并分泌巨噬细胞移动抑制因子(MIF)。在基质性角膜炎期间,会出现具有效应反应性的短暂病毒特异性淋巴细胞以及具有趋化活性的中性粒细胞。最后,抗体依赖性补体介导的细胞溶解提供了感染限制的另一个阶段。因此,有效管理和治疗眼部HSV疾病的基本原理必须基于对以下几点的理解:(1)由病毒引发的角膜炎症性疾病的免疫和免疫病理机制;(2)疾病恢复过程中的免疫机制;(3)病毒持续存在(潜伏)期间以及感染复发期间宿主的体液和细胞免疫状态。我们希望,通过评估体液和细胞免疫反应在疾病恢复和复发性疾病中的作用而获得的新信息,将为眼部HSV感染的管理提供新方法。